Sequenom Inc.

(SQNM) Trade

By |

Profile

Sequenom Inc was incorporated in 1994 under the laws of the State of Delaware. It is a life science company providing revolutionary genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. It develop and commercialize molecular diagnostics testing services that target and serve molecular diagnostics markets, and also develop and commercialize research use genetic analysis products and services that target and serve discovery and clinical research markets. It offers its services and products in the United States and international emphasis in countries like European and Asia-Pacific regions. The Company operates in two operating segments; Sequenom Laboratories and Sequenom Bioscience. Sequenom Laboratories provides molecular based, laboratory developed tests, or LDTs, with a focus principally on prenatal diseases and conditions and ophthalmological diseases and conditions. Sequenom Bioscience provides technology and research tools for genetic analysis and applications in translational research, clinical research, pharmacogenomics, oncology, and agricultural genomics. The Company's competitors include; Ariosa Diagnostics, Inc., Beijing Genomics Institute, Cellscape Corp., Celula Inc., Ikonysis, Inc., Kellbenx, Inc., Laboratory Corporation of America Holdings, Inc., Natera, Perkin Elmer, Inc., Quest Laboratories, Verinata and others. Its patent portfolio, including in-licensed patent rights, includes approximately 638 issued or allowed patents in the United States and other industrial nations throughout the world. Its prenatal diagnostic patent portfolio includes exclusive rights to numerous in-licensed issued patents. The Company is subject to federal, state and local laws and regulations governing the use, storage, handling and disposal of such materials and chemicals, as well as certain waste products.

Contact Information

Website: www.sequenom.com
Email: investorrelations@sequenom.com
Main Phone: +1 858 202-9000
Address: 3595 John Hopkins Court
Address 2: Suite 3700, P.O. Box 212
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Dirk Van Den Boom
Employees: 434
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)


Gathering Data... Please wait

Profile

Sequenom Inc was incorporated in 1994 under the laws of the State of Delaware. It is a life science company providing revolutionary genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. It develop and commercialize molecular diagnostics testing services that target and serve molecular diagnostics markets, and also develop and commercialize research use genetic analysis products and services that target and serve discovery and clinical research markets. It offers its services and products in the United States and international emphasis in countries like European and Asia-Pacific regions. The Company operates in two operating segments; Sequenom Laboratories and Sequenom Bioscience. Sequenom Laboratories provides molecular based, laboratory developed tests, or LDTs, with a focus principally on prenatal diseases and conditions and ophthalmological diseases and conditions. Sequenom Bioscience provides technology and research tools for genetic analysis and applications in translational research, clinical research, pharmacogenomics, oncology, and agricultural genomics. The Company's competitors include; Ariosa Diagnostics, Inc., Beijing Genomics Institute, Cellscape Corp., Celula Inc., Ikonysis, Inc., Kellbenx, Inc., Laboratory Corporation of America Holdings, Inc., Natera, Perkin Elmer, Inc., Quest Laboratories, Verinata and others. Its patent portfolio, including in-licensed patent rights, includes approximately 638 issued or allowed patents in the United States and other industrial nations throughout the world. Its prenatal diagnostic patent portfolio includes exclusive rights to numerous in-licensed issued patents. The Company is subject to federal, state and local laws and regulations governing the use, storage, handling and disposal of such materials and chemicals, as well as certain waste products.

Contact Information

Website: www.sequenom.com
Email: investorrelations@sequenom.com
Main Phone: +1 858 202-9000
Address: 3595 John Hopkins Court
Address 2: Suite 3700, P.O. Box 212
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
CEO: Dirk Van Den Boom
Employees: 434
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 2.53 52 Wk Low 0.82
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 119,243,357.00 EPS (TTM) -0.34 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Carolyn D. Beaver 1,000
Carolyn D. Beaver 1,000
Jeffrey D. Linton 1,000
Dirk Van Den Boom 1,000
Daniel S. Grosu 1,000
Jeffrey D. Linton 1,000
Carolyn D. Beaver 1,000
Carolyn D. Beaver 1,000
Dirk Van Den Boom 1,000
William J. Welch 1,000
Last 10 Sell Shares
Larry Myres 1,000
Larry Myres 1,000
Larry Myres 1,000
Clarke Neumann 1,000
Clarke Neumann 1,000
Clarke Neumann 1,000
Clarke Neumann 1,000
Larry Myres 1,000
Clarke Neumann 1,000
Clarke Neumann 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.4 2.4 2.4 2.4
Low Target Price Estimate 0.75 0.75 0.75 0.75
Mean Target Price Estimate 1.35 1.35 1.35 1.35
Standard Deviation 0.91 0.91 0.91 0.91
Date of Most Recent Estimate 08/19/16 08/19/16 08/19/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3 3 3 3